Monograph Details
|
|
Ob/Gyn
> Infertility
|
|
NOVAREL |
| Manufacturer |
|
Ferring Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Generic Name |
|
Chorionic gonadotropin 10000Units/10mL; pwd for IM inj after reconstitution; contains benzyl alcohol. |
| Indications |
|
Ovulation induction in women with secondary ovarian failure who have been pretreated with human gonadotropins. |
| Children |
|
Not applicable. |
| Adults |
|
5000–10000 Units IM one day after last dose of gonadotropins. |
| Contraindications |
|
Androgen- or estrogen-dependent neoplasm. Ovarian enlargement and overstimulation while on gonadotropin therapy. Primary ovarian failure. |
| Precautions |
|
Cardiac or renal disease. Epilepsy. Migraine. Asthma. Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Ovarian hyperstimulation or enlargement, ascites, pleural effusion, ovarian cyst rupture, multiple births, arterial thromboembolism, headache, irritability, restlessness, depression, fatigue, edema, gynecomastia, local reactions. |
| How Supplied |
|
Vial (10mL)—10 (w. diluent) |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
